AllQuantitative Report
logoArgusMarch 31, 2021

SUPN: What does Argus have to say about SUPN?

Symbols
SUPN
Sector(s)
Healthcare
Rating
Current Price
$30.54
Price Target
$NaN
Earnings Estimate
Summary

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free